SAS | The Power to Know
cq5dam.thumbnail.319.319
White Paper

Learning to Share - Sharing to Learn: Honoring Patients Through Collaboration and Transparency

Exploring the emerging trend of data-sharing initiatives in the life sciences industry

About this paper

Pressured by new regulations, public image issues, negative publicity and a desire to promote better use of health data, pharmaceutical companies and other clinical trial sponsors are starting initiatives to expose and share their clinical trial information. Recent announcements to share previously confidential data include those by GlaxoSmithKline and the CEO Roundtable on Cancer. In addition to positive media attention and altruistic reasons, pharmaceutical companies also see this as an opportunity to improve the research process and increase the opportunities to identify scientific breakthroughs helping both their companies as well as the larger healthcare environment. Providing access to clinical trial data with the ability to aggregate information for meta-analyses greatly increases the likelihood for identifying new medical breakthroughs as well as decreasing the time to market for

About SAS

SAS helps 80,000 organisations around the world take their data… And do amazing things… We help organisations turn large amounts of data into knowledge they can use, and we do it better than anyone. It’s no wonder an overwhelming majority of customers continue to use SAS year after year. Find out more, Why SAS?

 

Have a SAS profile? To complete this form automatically Sign In

*
*
*
*
 
*
*
 
 

Back to Top